Skip to main content
OpenTrials

Clinical trial condition

Hepatocellular Carcinoma

Explore clinical trials studying Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.

1,017 public trials 265 recruiting studies
Refine in advanced search Browse all conditions

Hepatocellular Carcinoma trial results

Recruiting

A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer

NCT06764316

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Dothan Dothan, Alabama, United States
  • Duarte Duarte, California, United States
  • Edegem Edegem, Antwerp, Belgium
  • Leuven Leuven, Flemish Brabant, Belgium
View all 24 locations
View Trial Details
Recruiting

Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

NCT07227012

Conditions
Adenocarcinoma, Advanced Hepatocellular Carcinoma, Carcinoma, +13 more
Locations
  • Keck Hospital of USC Los Angeles, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC/Norris Comprehensive Cancer Center / Investigational Drug Services Los Angeles, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 54 locations
View Trial Details
Recruiting

First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours

NCT06795022

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Baltimore, Maryland, United States
  • Research Site St Louis, Missouri, United States
View all 21 locations
View Trial Details
Recruiting

STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma

NCT06880523

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada
  • BCCA - Vancouver Vancouver, British Columbia, Canada
  • Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada
  • Kingston Health Sciences Centre Kingston, Ontario, Canada
View all 13 locations
View Trial Details
Recruiting

A Study of MGC026 in Participants With Advanced Solid Tumors

NCT06242470

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +102 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • START Midwest Grand Rapids, Michigan, United States
  • START-New York Long Island Lake Success, New York, United States
  • Providence Cancer Institute Portland, Oregon, United States
View Trial Details

Related conditions